Efficacy of regorafenib in the treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Regorafenib offers a survival advantage in advanced HCC but does not significantly improve tumor response rates compared to alternative therapies.
Authors
- Aimin Yue
- Zhang Cheng
Institutions
- Xinxiang Central Hospital (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.4251/wjgo.v18.i1.113816
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00